These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 29713782)

  • 1. Gd-EOB-DTPA-enhanced MRI for quantitative assessment of liver organ damage after partial hepatic ischaemia reperfusion injury: correlation with histology and serum biomarkers of liver cell injury.
    Getzin T; Gueler F; Hartleben B; Gutberlet M; Thorenz A; Chen R; Meier M; Bräsen JH; Derlin T; Hartung D; Lang HAS; Haller H; Wacker F; Rong S; Hueper K
    Eur Radiol; 2018 Oct; 28(10):4455-4464. PubMed ID: 29713782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the DWI and Gd-EOB-DTPA-enhanced MRI on assessing the hepatic ischemia and reperfusion injury after partial hepatectomy.
    Lu Y; Liu P; Fu P; Chen Y; Nan D; Yang X
    Biomed Pharmacother; 2017 Feb; 86():118-126. PubMed ID: 27951418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative evaluation of liver function with MRI Using Gd-EOB-DTPA.
    Ryeom HK; Kim SH; Kim JY; Kim HJ; Lee JM; Chang YM; Kim YS; Kang DS
    Korean J Radiol; 2004; 5(4):231-9. PubMed ID: 15637473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gd-EOB-DTPA-enhanced magnetic resonance imaging features of hepatic hemangioma compared with enhanced computed tomography.
    Tateyama A; Fukukura Y; Takumi K; Shindo T; Kumagae Y; Kamimura K; Nakajo M
    World J Gastroenterol; 2012 Nov; 18(43):6269-76. PubMed ID: 23180948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gadolinium-ethoxybenzyl-diethylenetriamine penta-acetic acid-enhanced magnetic resonance imaging for evaluating fibrosis regression in chronic hepatitis C patients after direct-acting antiviral.
    Li XH; Huang R; Yang M; Wang J; Gao YH; Jin Q; Ma DL; Wei L; Rao HY
    World J Gastroenterol; 2022 May; 28(20):2214-2226. PubMed ID: 35721884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gd-EOB-DTPA enhanced MRI of the liver: correlation of relative hepatic enhancement, relative renal enhancement, and liver to kidneys enhancement ratio with serum hepatic enzyme levels and eGFR.
    Talakic E; Steiner J; Kalmar P; Lutfi A; Quehenberger F; Reiter U; Fuchsjäger M; Schöllnast H
    Eur J Radiol; 2014 Apr; 83(4):607-11. PubMed ID: 24380639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential of Gd-EOB-DTPA as an imaging biomarker for liver injury estimation after radiation therapy.
    Sun XL; Jiang X; Kuang Y; Xing L; Bu LY; Yuan SH; Yu JM; Zheng SS
    Hepatobiliary Pancreat Dis Int; 2019 Aug; 18(4):354-359. PubMed ID: 31221569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gd-EOB-DTPA-enhanced-MR imaging in the inflammation stage of nonalcoholic steatohepatitis (NASH) in mice.
    Yamada T; Obata A; Kashiwagi Y; Rokugawa T; Matsushima S; Hamada T; Watabe H; Abe K
    Magn Reson Imaging; 2016 Jul; 34(6):724-729. PubMed ID: 26979540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced MR finding of radiation-induced hepatic injury: relationship to absorbed dose and time course after irradiation.
    Okamoto D; Nishie A; Asayama Y; Tajima T; Ishigami K; Kakihara D; Nakayama T; Ohga S; Yoshitake T; Shioyama Y; Honda H
    Magn Reson Imaging; 2014 Jul; 32(6):660-4. PubMed ID: 24666574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and validation of a predictor of insufficient enhancement during the hepatobiliary phase of Gd-EOB-DTPA-enhanced magnetic resonance imaging.
    Cui E; Long W; Luo L; Hu M; Huang L; Chen X
    Acta Radiol; 2017 Oct; 58(10):1174-1181. PubMed ID: 28090793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamic-contrast-enhanced magnetic resonance imaging of cirrhotic liver parenchyma: A comparison between gadolinium-diethylenetriamine pentaacetic acid and gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid.
    Lin CY; Chang WC; Chou CT; Chen RC
    J Chin Med Assoc; 2015 Nov; 78(11):666-72. PubMed ID: 26341453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing liver function by liver enhancement during the hepatobiliary phase with Gd-EOB-DTPA-enhanced MRI at 3 Tesla.
    Verloh N; Haimerl M; Zeman F; Schlabeck M; Barreiros A; Loss M; Schreyer AG; Stroszczynski C; Fellner C; Wiggermann P
    Eur Radiol; 2014 May; 24(5):1013-9. PubMed ID: 24531844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamic contrast-enhanced MRI of the liver in Mrp2-deficient rats using the hepatobiliary contrast agent Gd-EOB-DTPA.
    Saito S; Obata A; Kashiwagi Y; Abe K; Murase K
    Invest Radiol; 2013 Jul; 48(7):548-53. PubMed ID: 23442774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantifying differences in hepatic uptake of the liver specific contrast agents Gd-EOB-DTPA and Gd-BOPTA: a pilot study.
    Dahlqvist Leinhard O; Dahlström N; Kihlberg J; Sandström P; Brismar TB; Smedby O; Lundberg P
    Eur Radiol; 2012 Mar; 22(3):642-53. PubMed ID: 21984449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does gadoxetate disodium affect MRE measurements in the delayed hepatobiliary phase?
    Plaikner M; Kremser C; Zoller H; Steurer M; Glodny B; Jaschke W; Henninger B
    Eur Radiol; 2019 Feb; 29(2):829-837. PubMed ID: 30027410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired hepatic Gd-EOB-DTPA enhancement after radioembolisation of liver malignancies.
    Powerski MJ; Scheurig-Münkler C; Hamm B; Gebauer B
    J Med Imaging Radiat Oncol; 2014 Aug; 58(4):472-80. PubMed ID: 24964737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Fenestra VC Contrast-enhanced computed tomography imaging with gadopentetate dimeglumine and ferucarbotran magnetic resonance imaging for the in vivo evaluation of murine liver damage after ischemia and reperfusion.
    Choukèr A; Lizak M; Schimel D; Helmberger T; Ward JM; Despres D; Kaufmann I; Bruns C; Löhe F; Ohta A; Sitkovsky MV; Klaunberg B; Thiel M
    Invest Radiol; 2008 Feb; 43(2):77-91. PubMed ID: 18197060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gd-EOB enhanced MRI T1-weighted 3D-GRE with and without elevated flip angle modulation for threshold-based liver volume segmentation.
    Grieser C; Denecke T; Rothe JH; Geisel D; Stelter L; Cannon Walter T; Seehofer D; Steffen IG
    Acta Radiol; 2015 Dec; 56(12):1419-27. PubMed ID: 25406435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatobiliary magnetic resonance imaging in patients with liver disease: correlation of liver enhancement with biochemical liver function tests.
    Kukuk GM; Schaefer SG; Fimmers R; Hadizadeh DR; Ezziddin S; Spengler U; Schild HH; Willinek WA
    Eur Radiol; 2014 Oct; 24(10):2482-90. PubMed ID: 25030459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feasibility of self-gated isotropic radial late-phase MR imaging of the liver.
    Weiss J; Taron J; Othman AE; Grimm R; Kuendel M; Martirosian P; Ruff C; Schraml C; Nikolaou K; Notohamiprodjo M
    Eur Radiol; 2017 Mar; 27(3):985-994. PubMed ID: 27271925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.